Literature DB >> 9339716

Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction.

Y Ito1, H Niwa, T Iida, M Nagamatsu, T Yasuda, T Yanagi, G Sobue.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9339716     DOI： 10.1212/wnl.49.4.1174

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  19 in total

1.  Blood transfusion-induced irreversible brain damage.

Authors:  Hikaru Nagasawa; Keiji Kurita; Manabu Wada; Toru Kawanami; Takeo Kato
Journal:  J Neurol       Date:  2005-06-06       Impact factor: 4.849

2.  Posterior reversible encephalopathy syndrome resulting from repeat bortezomib usage.

Authors:  N A Nixon; K Parhar
Journal:  BMJ Case Rep       Date:  2014-06-05

3.  Reversible tacrolimus-induced neurotoxicity isolated to the brain stem.

Authors:  P J Oliverio; L Restrepo; S A Mitchell; C S Tornatore; S R Frankel
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

4.  Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy.

Authors:  A Ozkan; B Hakyemez; F Ozkalemkas; R Ali; V Ozkocaman; T Ozcelik; O Taskapilioglu; Y Altundal; A Tunali
Journal:  Neuroradiology       Date:  2006-09-16       Impact factor: 2.804

Review 5.  Reversible posterior leukoencephalopathy syndrome after blood transfusion in a patient with end-stage renal disease.

Authors:  Yoshinori Sato; Makoto Hirose; Yoshihiko Inoue; Daisuke Komukai; Mamiko Takayasu; Eri Kawashima; Fumihiko Koiwa; Ashio Yoshimura
Journal:  Clin Exp Nephrol       Date:  2011-09-07       Impact factor: 2.801

6.  Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Authors:  Christina Mueller-Mang; Thomas Mang; Agnes Pirker; Katharina Klein; Christine Prchla; Daniela Prayer
Journal:  Neuroradiology       Date:  2009-02-21       Impact factor: 2.804

7.  Assessment of Noninvasive Regional Brain Oximetry in Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.

Authors:  David Y Chung; Jan Claassen; Sachin Agarwal; J Michael Schmidt; Stephan A Mayer
Journal:  J Intensive Care Med       Date:  2016-01-05       Impact factor: 3.510

8.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 9.  Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature.

Authors:  Hakan Gümüş; Hüseyin Per; Sefer Kumandaş; Ali Yikilmaz
Journal:  Neurol Sci       Date:  2009-10-07       Impact factor: 3.307

10.  Reversible posterior leukoencephalopathy syndrome in sickle-cell anemia.

Authors:  Richard E Frye
Journal:  Pediatr Neurol       Date:  2009-04       Impact factor: 3.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.